SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of postoperative
administration of SPRIX in pediatric patients (ages 0-11) undergoing open surgical
procedures.